Isoflavones: effects on bone health.

Climacteric

Institut Clinic of Gynecology, Obstetrics and Neonatology, Faculty of Medicine, University of Barcelona, and Hospital Clinic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Published: April 2011

Background: There are many effects described, both experimental and clinical, that assess the relationship between isoflavones and bone. It has been hypothesized that isoflavones may have a positive effect on bone health.

Objective: To review the effects of isoflavones on biochemical markers of bone remodeling, bone density and bone quality, and finally on fracture incidence.

Methods: A systematic review was carried out of in vitro, animal, and human studies involving isoflavones and bone health. An electronic search was made, based on Internet search engines, MEDLINE (1966-June 2010) and the Cochrane Controlled Clinical Trials Register. This search was further supplemented by a hand-search of reference lists of selected review papers.

Results: After crossing-cleaning the reference lists, 737 studies dealing with isoflavones and bone were identified. Of these, 36 were considered selectable. From in vitro and animal studies, isoflavones appear to stimulate osteoblastic bone formation and inhibit osteoclastic bone resorption. Reviewed data show evidence of a beneficial effect of isoflavones on bone health in peri- and postmenopausal women when high-isoflavone soy protein is incorporated in the diet. Inconsistencies observed among data from different studies are related to differences in study design, the variety of soy sources of isoflavones, time of analysis, and the variability in the bioavailability and metabolism of isoflavones.

Conclusions: Most of the studies suggested a positive relationship between isoflavones and bone health. Further well-controlled, randomized, double-blind, clinical trials with a larger sample population, longer duration, and examination of various dosages are needed to better elucidate the inter-relationship between isoflavones and bone loss and to clarify whether isoflavones could prevent bone fractures.

Download full-text PDF

Source
http://dx.doi.org/10.3109/13697137.2010.529198DOI Listing

Publication Analysis

Top Keywords

isoflavones bone
24
bone health
16
bone
14
isoflavones
12
relationship isoflavones
8
vitro animal
8
clinical trials
8
reference lists
8
studies
5
isoflavones effects
4

Similar Publications

Unlabelled: This study examined how isoflavone interventions impact bone health in postmenopausal women. Analyzing 73 trials found that isoflavones reduce bone resorption markers, enhance bone minerals, and increase hormones regulating bone metabolism. This suggests that isoflavones could help address bone health issues in postmenopausal women.

View Article and Find Full Text PDF
Article Synopsis
  • Ipriflavone (IPRI) is used to prevent postmenopausal bone loss and offers antioxidant and cognitive benefits, but it has low bioavailability due to poor solubility.
  • In this study, IPRI was formulated into targeted poly-lactic-co-glycolic acid (PLGA) nanoparticles with Tet-1 peptide to enhance its therapeutic effects in a rat model of Alzheimer's disease (AD), exacerbated by streptozotocin (STZ) injections.
  • Results showed that IPRI nanoparticles were more effective than free IPRI in reducing cognitive dysfunction, oxidative stress, and neurodegenerative changes, leading to improved neuronal cell viability and reduced Alzheimer's
View Article and Find Full Text PDF

Sappanone A (SAP), a high-isoflavone compound derived from the traditional Chinese medicine Sumu, exhibits various pharmacological activities, including anti-inflammatory and anti-oxidant effects. However, its protective effects on the liver have rarely been reported. The aim of this study was to investigate the effects of SAP on immune-mediated liver injury induced by concanavalin A (Con A) in mice and to explore the underlying molecular mechanisms.

View Article and Find Full Text PDF

JM053 alleviates osteoporosis in rats by increasing the content of soy isoflavone aglycones in fermented soymilk.

Food Funct

December 2024

Key Laboratory of Dairy Science, Ministry of Education, College of Food Science, Northeast Agricultural University, Harbin, 150030, China.

JM053 has a significant ability to convert soy isoflavones and can be used as a fermentation strain to ferment soymilk, thereby increasing the content of free aglycones in soymilk and thus providing an effective method to alleviate osteoporosis symptoms. This study aims to establish a rat model of osteoporosis induced by dexamethasone (DEX) and clarify the alleviating effect of soymilk fermented with JM053 on osteoporosis. Research has shown that fermented soymilk with JM053 can inhibit weight loss in rats caused by DEX, regulate the expression of inflammatory factors such as tumor necrosis factor-α (TNF-α) towards normal levels, and increase levels of alkaline phosphatase (ALP) and osteocalcin (OCN) to promote bone synthesis.

View Article and Find Full Text PDF

Objective: Sappanone A (SA), a bioactive compound in Caesalpinia sappan L., has anti-inflammation, antioxidant, and bone protection activities. But its effect on rheumatoid arthritis (RA) and the underlying mechanism are incompletely understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!